All sites C00-96,D32-33,D42-43,D45-47,D76 212 90.3 4.0 1.8 1.8 2.2
Mouth, pharynx C00-14 6 96.6 3.4 - - -
  Lip C00 2 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 0 100.0 - - - -
  Pharynx C01,C09-14 2 87.5 12.5 - - -
Digestive organs C15-26 42 88.5 2.9 3.4 1.9 3.4
  Oesophagus C15 4 100.0 - - - -
  Stomach C16 5 100.0 - - - -
  Small intestine C17 1 100.0 - - - -
  Colon C18 12 93.3 1.7 5.0 - -
  Rectum, rectosigmoid C19-20 8 100.0 - - - -
  Anus C21 - - - - - -
  Liver C22 4 100.0 - - - -
  Gallbladder, bile ducts C23-24 1 40.0 20.0 - - 40.0
  Pancreas C25 6 48.4 12.9 12.9 9.7 16.1
  Other digestive organs C26 1 66.7 - - 33.3 -
Respiratory organs C30-39 28 64.3 19.3 5.0 7.1 4.3
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 0 100.0 - - - -
  Lung, trachea C33-34 27 63.0 20.0 5.2 7.4 4.4
  Mediastinum, pleura C38 0 100.0 - - - -
Bone C40-41 0 100.0 - - - -
Melanoma of the skin C43 8 100.0 - - - -
Skin, non-melanoma C44 13 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 2 100.0 - - - -
Breast C50 1 100.0 - - - -
Male genital organs C60-63 71 98.9 - 0.3 0.6 0.3
  Prostate C61 67 98.8 - 0.3 0.6 0.3
  Testis C62 2 100.0 - - - -
  Other male genital C60,C63 2 100.0 - - - -
Urinary organs C64-68 14 90.3 1.4 1.4 4.2 2.8
  Kidney C64 6 85.7 - 3.6 3.6 7.1
  Bladder and urinary tract2 C65-68 9 93.2 2.3 - 4.5 -
Eye C69 0 - - - - 100.0
Brain, central nervous system C70-72,D32-33,D42-43 4 100.0 - - - -
Thyroid gland C73 1 100.0 - - - -
Other endocrine glands C74-75 0 50.0 50.0 - - -
Illdefined or unknown C76,C80 3 68.8 6.3 18.8 - 6.3
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 19 89.7 5.2 - - 5.2
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 6 100.0 - - - -
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 4 83.3 5.6 - - 11.1
  Leukaemia C91-95 6 86.2 13.8 - - -
  Myelodysplastic syndromes D46 1 80.0 - - - 20.0
  Myeloproliferaitive neoplasms D45,D47 1 71.4 - - - 28.6
Not included above
  Basal cell carcinoma of the skin 49 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.